Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02989064
Title MAGE-A10c796T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adaptimmune

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma


head and neck squamous cell carcinoma

Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Washington University - School of Medicine Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Tennessee Oncology - Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt - Ingram Cancer Center Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G1X6 Canada Details
Start Madrid-FJD, Fundación Jimѐnez Díaz Madrid 28040 Spain Details
Hospital Universitario 12 Octubre Avda. de Córdoba Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from for the field